Kolon Investment

Mainline is a technology company that specializes in developing cloud-based document management solutions using artificial intelligence. Its platform, which incorporates intelligent document processing (IDP) technologies such as machine learning, natural language processing, and optical character recognition, is designed to streamline and automate the processing of documents. More than 300 government agencies in South Korea currently utilize Mainline's system to enhance their document workflows. Recently, the company has introduced software that enables insurance companies to swiftly develop new products by simply modifying a single document, significantly reducing the time required for product development from several months to just one week. This innovative solution is also applicable to various organizations handling complex documents, including regulatory materials and contracts.

Founded in 2016, Neurophet is a neuroscience company based in Seoul, South Korea. It specializes in developing advanced brain stimulation simulation software, Neurophet tES Lab, and neuro-navigation technology to aid clinicians in treating patients with brain diseases.

My Franchise is a company founded in 2019 in Seoul, South Korea, that focuses on bridging the gap between franchise headquarters and prospective founders. It has developed an online platform that serves as a resource for these two parties, facilitating a partnership that is mutually beneficial. The platform provides valuable startup information, such as the number of franchisees over the years, average sales figures, and the associated startup costs of domestic franchise brands. This allows prospective founders to effectively compare and analyze important brand information, categorized by industry, helping them make informed decisions in their franchise endeavors.

Kimcaddie is a company based in Seoul, South Korea, founded in 2019. It operates an online platform that serves as a comprehensive resource for golf enthusiasts, offering information about nearby golf stores. Users can find details on store locations, read reviews, and learn about available facilities. Additionally, Kimcaddie provides a screen golf platform, enhancing the overall golf experience by integrating various aspects of the sport. The company aims to connect golfers with relevant resources and improve access to golf-related services.

Uneedcomms, Inc. is a South Korean company established in 2014 that specializes in developing data-driven e-commerce, mobile, and marketing solutions. Its flagship products include SMARTSKIN, a mobile shopping application that enhances the user experience, and TARGETBOOK, an advanced advertising management tool that leverages big data to analyze consumer behavior in shopping malls. TARGETBOOK synchronizes product information in real time, allowing for dynamic advertising of items currently available in retail spaces. Additionally, it automates the creation and editing of marketing creatives, aimed at optimizing advertising efforts. Uneedcomms focuses on empowering small and medium-sized e-commerce businesses by automating repetitive tasks, enabling operators to concentrate on more strategic endeavors to succeed in the competitive digital marketplace.

Y-Biologics Inc. is a biotechnology company based in Daejeon, South Korea, specializing in the discovery and development of novel antibody therapeutics, particularly in the field of immuno-oncology. Established in 2007, the company has developed a bispecific antibody platform technology known as AliCE, which maintains the structural integrity of the parental antibody, ensuring high binding affinity to cancer antigens. Additionally, Y-Biologics has created the Y-max ABL, a unique library of human antibodies, which supports its research and development efforts. The company is recognized for its contributions to the global immuno-chemotherapeutic drug market and also offers contract research services, aiming to advance its position within the biotechnology sector.

Cyrus Therapeutics is a biotechnology company focused on the research and development of innovative drugs aimed at addressing chronic and life-threatening diseases with significant unmet medical needs. Incorporated in 2019 and based in Seoul, South Korea, the company specializes in discovering and developing molecular medicines for conditions related to metabolism, obesity, metastasis, and refractory issues. Utilizing a range of advanced drug modalities, including traditional small molecule inhibitors and targeted protein degraders, Cyrus Therapeutics is dedicated to developing treatment options for patients who are often considered undruggable.

Founded in Seoul, South Korea in 2017, Happy Moonday specializes in the manufacture and sale of organic sanitary pads and related products. Its mission is to empower women by providing high-quality, organic healthcare solutions.

Founded in 2016, Neurophet is a neuroscience company based in Seoul, South Korea. It specializes in developing advanced brain stimulation simulation software, Neurophet tES Lab, and neuro-navigation technology to aid clinicians in treating patients with brain diseases.

Kanaph Therapeutics is a biotechnology company focused on developing next-generation therapeutics for oncology and autoimmune diseases. Founded in 2019 and headquartered in Seoul, South Korea, the company engages in drug development activities ranging from discovery to early-stage clinical trials. Its therapeutic platform includes bi-specific antibodies, Fc-fusions, and small molecules. In oncology, Kanaph Therapeutics develops drugs with enhanced immuno-stimulatory activity in the tumor microenvironment for efficient tumor eradication. For autoimmune diseases, the company's pipeline features bispecific Fc-fusions that inhibit the alternative complement pathway, angiogenesis, and downstream complement activation. The company serves both Korea and the United States.

Cyrus Therapeutics is a biotechnology company focused on the research and development of innovative drugs aimed at addressing chronic and life-threatening diseases with significant unmet medical needs. Incorporated in 2019 and based in Seoul, South Korea, the company specializes in discovering and developing molecular medicines for conditions related to metabolism, obesity, metastasis, and refractory issues. Utilizing a range of advanced drug modalities, including traditional small molecule inhibitors and targeted protein degraders, Cyrus Therapeutics is dedicated to developing treatment options for patients who are often considered undruggable.

The Pirates Co., Ltd. specializes in the development and operation of a mobile application that serves both wholesale and retail markets for seafood products. Established in 2018 and headquartered in Seoul, South Korea, the company also operates an aquatic market news platform that delivers information on fresh seafood offerings. This platform connects consumers with suppliers, providing essential insights into the quality of marine products and facilitating informed purchasing decisions. Through its innovative approach, The Pirates aims to enhance the seafood purchasing experience by bridging the gap between consumers and the fish market.

Spendit is a B2B fintech company in Seoul, Korea.

Founded in 2016, Neurophet is a neuroscience company based in Seoul, South Korea. It specializes in developing advanced brain stimulation simulation software, Neurophet tES Lab, and neuro-navigation technology to aid clinicians in treating patients with brain diseases.

Korea Credit Data Co., Ltd. is a Seoul-based company that specializes in developing business management software, particularly for small and medium enterprises. Founded in 2016, its flagship product, CashNote, enables users to manage card payment schedules, conduct customer analysis, and perform tax invoice inquiries. In addition to CashNote, Korea Credit Data offers a range of services that include customer analysis, point-of-sale (POS) systems, and payment solutions through its various subsidiaries. The company serves over two million businesses in Korea, aiming to address challenges faced by business owners throughout their operational lifecycle. By forming strategic partnerships with leading industry players, Korea Credit Data has established a strong market presence and expanded its offerings to include payment networks and credit bureau services, enhancing its ability to support its clients effectively.

Dunamu is a Seoul-based technology company that develops and operates digital asset and blockchain-related services. It runs UPbit, a cryptocurrency exchange with presence in Korea, Indonesia, Thailand, and Singapore, and Luniverse, a blockchain platform, along with UBCI, a cryptocurrency market index. The company also provides securities information and trading through Stockplus and an OTC platform for private companies via U-Stockplus, as well as Onboard, an equity-management platform for private firms. It offers investment services and mobile access to its platforms, enabling users to trade digital assets, access market data, and manage private equity electronically. Founded in 2012, Dunamu focuses on connecting users with digital assets, blockchain infrastructure, and private-market services across its platforms.

Eutilex Co., Ltd. is a South Korean biotechnology company specializing in the development of innovative immunotherapy technologies. The firm focuses on anti-tumor treatments, specifically anti-tumor T cell therapy and antibody therapeutics. Its product pipeline includes notable therapies such as T Cell Therapy (4-1BB CTL) and CAR-T, which are designed to enhance the body's immune response against cancer. Eutilex markets its therapeutic innovations throughout South Korea, aiming to advance cancer treatment through its cutting-edge approaches in immunotherapy.

Founded in 2014, Newploy is a South Korean company that develops a platform for automating payroll tasks using robotic process automation technology. Its software enables businesses to manage and centralize various aspects of staffing needs, including leave management, attendance tracking, work scheduling, and payroll calculation.

AptaBio Therapeutics Inc. is a pharmaceutical biotechnology company based in Yongin-Si, South Korea, focused on discovering and developing innovative treatments, particularly selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs. The company offers a range of transfection reagents, including Lipofector-Q, Lipofector-EXT, Lipofector-2000, Lipofector-EZ, and Lipofector-pMAX, designed to facilitate the introduction of DNA or RNA into eukaryotic cells. AptaBio's product pipeline includes several candidates, such as PX-115 for diabetic nephropathy, APX-1004 for diabetic retinopathy, and APX-311 intended for the treatment of non-alcoholic steatohepatitis (NASH). Founded in 2009, AptaBio Therapeutics aims to address significant medical needs through its innovative drug development efforts.

C-TRI is involved in the manufacturing and advancement of pharmaceutical products. C-Tri Co., Ltd., based in Namyangju, South Korea, specializes in the production and development of pharmaceutical products. They offer a wide range of products, including peptides, antiviral drugs, ionic liquids, and more. Additionally, C-Tri Co., Ltd. provides OTC and ETC contract services. The company was established in 1998.

SeeOn (씨온) is a Korean location-based social network service that allows users to contact other users and share experiences with one another. Established in 2012, SeeOn was awarded the social networking app of the year in 2012 in the LBS smart app awards.

SundayToz Corp. is a South Korean company specializing in the development of casual social games. Founded in 2009 and headquartered in Seongnam, Gyeonggi-do, the company has created games for a variety of platforms, including Kakao Talk, Apple's App Store, Google Play, Facebook, and Naver. SundayToz gained recognition for its innovative content, receiving the Republic of Korea Presidential Award in December 2012 for next-generation-targeted content. The company launched its first application, Cyworld, in December 2009, marking the beginning of its contributions to the gaming industry.